Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
| Line 676: | Line 676: | ||
*Citation: O'Cleirigh C, King D, Stanton AM, Goldin A, Kirakosian N, Crane HM, Grasso C. Patterns of E-Cigarette Use Among Primary Care Patients at an Urban Community Center. J Community Health. 2021 Jul 2. doi: 10.1007/s10900-021-01015-x. Epub ahead of print. PMID: 34215994. | *Citation: O'Cleirigh C, King D, Stanton AM, Goldin A, Kirakosian N, Crane HM, Grasso C. Patterns of E-Cigarette Use Among Primary Care Patients at an Urban Community Center. J Community Health. 2021 Jul 2. doi: 10.1007/s10900-021-01015-x. Epub ahead of print. PMID: 34215994. | ||
*Acknowledgement: The data is owned by a third-party organization (Fenway Health), and the organization’s IRB restricts access to patient data, due to concerns over a risk of inadvertent disclosure of personal health information. Given that the data are abstracted from patients’ primary care medical visits, the preparation of deidentified data is not permitted. Researchers with a reasonable request for a deidentified data set can contact the Fenway Health IRB | *Acknowledgement: The data is owned by a third-party organization (Fenway Health), and the organization’s IRB restricts access to patient data, due to concerns over a risk of inadvertent disclosure of personal health information. Given that the data are abstracted from patients’ primary care medical visits, the preparation of deidentified data is not permitted. Researchers with a reasonable request for a deidentified data set can contact the Fenway Health IRB | ||
======2021: [https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30307-8/fulltext Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial]=== | |||
*A targeted self-help intervention with high potential for dissemination could be efficacious in promoting smoking cessation among dual users of combustible cigarettes and e-cigarettes. | |||
*[https://www.thelancet.com/action/showPdf?pii=S2468-2667%2820%2930307-8 PDF Version] | |||
*Citation: doi: 10.1016/S2468-2667(20)30307-8 | |||
*Acknowledgement: This work was supported by the National Institute on Drug Abuse of the NIH (R01DA037961). his work has also been supported in part by the Biostatistics and Bioinformatics Shared Resource and the Participant Research, Interventions, and Measures Resource at the H Lee Moffitt Cancer Center and Research Institute, a National Cancer Institute designated Comprehensive Cancer Center (P30CA76292). | |||